NSETrading Window28 Sept 2026 · 28 Sept 2026, 12:31 pm

Trading Window

Medicamen Biotech Limited · MEDICAMEQ

✦ AI Summary

Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in the securities of the Company will be closed for all Designated Persons from October 01, 2026 till 48 hours after the announcement of the Financial Results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

MEDICAMEQ_28092026123044_Trading_window_closure-Intimation.pdf

pdf

Download →
View document text
Date: 28.09.2026 BSE Limited National Stock Exchange of India Limited 25th Floor Exchange Plaza, C-1, Phiroze Jeejebhoy Towers Block - G Bandra Kurla Dalal Street, Mumbai 400 001 Complex Bandra (East) Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub. : Intimation of Closure of Trading Window Dear Sir, Pursuant to the Code of Conduct for Prevention of Insider Trading adopted by the Medicamen Biotech Limited (‘Company’) under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all Designated Persons (including their immediate relatives) from Thursday, October 01, 2026 till 48 hours after the announcement of the Financial Results for the quarter and half year ending September 30, 2026 (‘Financial Results’) to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of trading window. The date of the Board Meeting of the Company for approval of Financial Results will be intimated in due course. The above details will also be available on the website of the Company at www.medicamen.com under Investor Relations section. We request you to take the same on record. Thanking You. Yours Faithfully For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS-44157